Navigation Links
Rigel to Webcast Investor Update on October 27, 2008
Date:10/21/2008

SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will webcast its investor update, in conjunction with the American College of Rheumatology Meeting (ACR), on October 27, 2008 from 2:00-3:00pm Pacific Time. Members of Rigel's senior management team will provide an update on the company's lead product candidate, R788, a novel, oral Syk kinase inhibitor. R788 is currently being evaluated in two Phase 2b clinical trials in patients with rheumatoid arthritis, as well as Phase 2 clinical trials in immune thrombocytopenic purpura and B-cell lymphomas.

The event will be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary. The webcast will be archived and available for replay on the Company's website.

In addition, Rigel will be participating in both a plenary session and a poster session during ACR in San Francisco, California from October 24-29, 2008.

ACR Presentation Details

Plenary session: Monday, Oct 27, 12:15-12:30 PM

Session: Discovery 2008: Pathogenesis and Treatment of Inflammatory

Arthritis

Title: 1189 - Treatment of Rheumatoid Arthritis (RA) with a Syk Kinase

Inhibitor: A 12-week randomized placebo controlled study

Location: Hall C

Poster session: Tuesday, Oct 28, 9:00-11:00 AM

Session: Biology and Pathology of Bone and Cartilage

Title: 1293 - R406, a Small Molecule Syk inhibitor, Suppresses Osteoclast

Differentiation of Murine Bone Mar
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Rigel Announces Third Quarter 2007 Financial Results
2. Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
3. Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP
4. Rigel Announces Offering of 4,000,000 Shares of Common Stock
5. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
6. Rigel Announces Participation in Upcoming Investor and Partnering Conferences
7. Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
8. Rigel Announces First Quarter 2008 Financial Results
9. Rigel to Present at Collins Stewart Growth Conference
10. QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
11. Webcast Alert: Kaiser Permanente Residency Program Open House
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The time to deploy Ebola vaccines is now, ... is now, according to a commentary being published early ... . The authors from Yale School of Public ... dissemination of the current Ebola outbreak represent a public ... current efforts. Several Ebola vaccines have been developed in ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... exercise may help older women avoid a condition that causes ... active postmenopausal women had a 10 percent lower risk of ... researchers report in the Aug. 20 issue of the ... enjoyed this protection against the heart rhythm disorder even if ...
(Date:8/20/2014)... is one of the most persistent and deadliest infectious ... people each year. , Scientists who study tuberculosis have ... likely spread from humans in Africa to seals and ... and transmitted it to Native people there before Europeans ... Genomes Reveal Seals as a Source of New World ...
(Date:8/20/2014)... found a novel approach to treating cancer - using ... of Science Translational Medicine shows that cancer ... by nerves that are linked to cancer stem cells. ... Botox made the treatment cheap, safe and efficient. The ... and will soon start testing on humans. , The ...
(Date:8/20/2014)... WI (PRWEB) August 20, 2014 Quincy ... the Inc. 500|5000 list of the fastest growing ... consecutive year. Ranking at No. 2,941, Quincy Bioscience is ... businesses in the United States. , Quincy Bioscience is ... ingredient apoaequorin – a protein originally discovered in jellyfish ...
Breaking Medicine News(10 mins):Health News:News from Annals of Internal Medicine 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2
... will create a calendar-like printout every time a prescription ... and associate dean, who wanted to reduce consumer confusion ... confusing: knowing which pill is which, when to take ... ,'The idea came to me when a ...
... could kill brain cells and raise the risk of ... the drug. ,Isoflurane is an anaesthetic, which is ... ,Many people, especially the elderly, suffer ... scrambling and delirium that can last six hours or ...
... surgical technique pioneered at the University of Alberta has ... tongue cancer.// ,By modifying an existing technique ... tongue, surgeons can provide enough bulk to help improve ... a 'jellyroll'of fat and connective tissue along with the ...
... at Virginia Commonwealth University's Massey Cancer Center have created ... ,This new method improves the antileukemic activity of a ... that could lead to more effective strategies for fighting ... process, or apoptosis, is characteristically impaired in cancer cells. ...
... on your wish list this holiday season? It’s one of the ... may leave you with back, neck and shoulder pain, headaches and ... with neck pains and headaches and what I usually do is ... M.D., family practice physician on the medical staff at Baylor Medical ...
... of cancer death in the U.S.; more than 30,000 Americans ... ,Pancreatic cancer is an extremely difficult cancer to treat ... risk factor in pancreatic cancer is cigarette smoking; other links ... resistance. In a new study, researchers at the Harvard School ...
Cached Medicine News:Health News:New Software to Help Patients 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 3Health News:New Method For Fighting Leukemia 2Health News:Link Found Between Periodontal Disease and Pancreatic Cancer 2
(Date:8/20/2014)... Research and Markets  has announced the addition of the ... Global Market Report of Pralmorelin (CAS 158861-67-7) ... ( Europe , Asia , ... etc.). It captures Pralmorelin market trends, pays close ... primary areas; manufacture methods & technology development, market situation & ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for Coatings ... following Product Segments: Active Coatings, Protective Coatings, Optical ... comprehensive analytics for the US, Canada ...
(Date:8/20/2014)... SALT LAKE CITY , Aug. 20, 2014 /PRNewswire/ ... their revolutionary mobile diagnostic platform during a special event ... City, Utah , on September 5, 2014. The ... be LiveStreamed on the ApolloDx website, www.apollodx.com .  ... will transform diagnostic testing," said Jared Bauer , ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
Binkhorst, length 35 mm....
Army navy retractor set....
Rigid neck rake retractor, 3 sharp prong....
Rees bayonet forceps, standard, 5-1/2", TC....
Medicine Products: